InfuSystem Holdings (INFU) Depreciation & Amortization (CF) (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Depreciation & Amortization (CF) came in at $3.0 million in Q1 2026, down 0.91% YoY from $3.1 million in Q1 2025, and down 3.0% on a QoQ basis from $3.1 million in Q4 2025.
InfuSystem Holdings (INFU) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $3.0 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 0.91% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (up 3.5% YoY) and the FY2025 annual result came in at $12.4 million, up 7.53% from the prior year.
- Depreciation & Amortization (CF) declined to $3.0 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.2 million in Q4 2024 to a low of $2.7 million in Q1 2024.
- A 5-year average of $2.9 million and a median of $2.9 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) declined 26.51% — and 2025, when it advanced 15.84%.
- Tracing INFU's Depreciation & Amortization (CF) over 5 years: stood at $2.7 million in 2022, then increased by 5.92% to $2.9 million in 2023, then rose by 9.53% to $3.2 million in 2024, then retreated by 1.1% to $3.1 million in 2025, then fell by 3.0% to $3.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $3.0 million (Q1 2026), $3.1 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.65 Mn |